Definition of a diagnostic routine in individuals with inconclusive serology for chagas disease

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 226-233

  Picka, Mariele Cristina Modolo ^a   Meira, Domingos Alves ^a   de Carvalho, Thaís Batista ^a   Peresi, Eliana ^a   Marcondes Machado, Jussara ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Chronic chagasic infection; Immunoblotting; Inconclusive serology; Trypanosoma cruzi

Indexed keywords

ADULT; ARTICLE; BLOOD CULTURE; BRAZIL; CHAGAS DISEASE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; XENODIAGNOSIS;

EID: 34547127381     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000200012     Document Type: Article

References (52)

1. World Health Organization. Chagas disease, Brazil: interruption of transmission. Weekly Epidemiological Record 2000;75:153-6.
2. Tarleton R.L.Parasite persistence in the aectiology of Chagas disease. Int J Parasitol 2001;31:550-4.
3. Ferreira M.S., Lopes E.R., Chapadeiro E., et al. Doença de Chagas. In: Veronesi R, Focaccia R. Tratado de infectologia. São Paulo: Atheneu; 1997.
4. Luquetti J.A., Rassi A. Diagnóstico laboratorial da infecção pelo Trypanosoma cruzi. In: Brener Z., Andrade Z.A., Barral-Neto M., editores. Trypanosoma cruzi e doença de Chagas. 2a ed. Rio de Janeiro: Guanabara Koogan: 2000.
5. Pirard M., Lihoshi N., Boelaert M., et al. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005; 45:554-61.
6. Streiger M.L., del Barco M.L., Fabbro D.L., et al. Longitudinal study and specific chemotherapy in children with chronic chagas disease, residing in a low endemicity area of Argentina. Rev Soc Bras Med Trop 2004;37:365-75.
7. Pompilio M.A., Dorval M.E., Cunha R.V., et al. Epidemiological, clinical and parasitological aspects of Chagas' disease in Mato Grosso do Sul State. Rev Soc Bras Med Trop 2005;38:473-8.
8. Maldonado C., Albano S., Vettorazzi L., et al. Using Polymerase Chain Reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation. J Heart Lung Transplant 2004;23:1345-8.
9. Umezawa E.S., Bastos S.F., Coura J.R., et al. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion 2003;43:91-7.
10. Gomes YM. PCR and sero-diagnosis of Chagas'disease: biotechnological advances. Appl Biochem Biotechnol. 1997;66:107-19
11. Britto C., Cardoso M.A., Vanni C.M.M., et al. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation.. Parasitology 1995;110:241-7.
12. Junqueira A.C.V., Chiari E., Wincker P. Comparison of the polymerase chain reaction with two classical parasitological methods for the diagnosis of Chagas disease in an endemic region of north-eastern Brazil. Trans R Soc Trop Med Hyg. 1996;90:129-32.
13. Sturm N.R., Degrave W., Morel C., Simpson L. Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas' disease. Mol Biochem Parasitol 1989;33:205-14.
14. Avila H.A., Sigman D.S., Cohen L.M., et al. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of Chagas'disease. Mol Biochem Parasitol 1991;48:211-22.
15. Gomes M.L. Trypanosoma cruzi: use of an optimized PCR method in chronic chagas disease diagnosis, and molecular characterization of strains isolated from chronic chagasic individuals living in northwest Paraná, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 1998;31:327-8.
16. Amato Neto V., De Marchi C.R., Ferreira C.S., Ferreira A.W. Observations on the use of TESA blot for the serological diagnosis of Chagas' disease. Rev Soc Bras Med Trop 2005;38:534-5.
17. Matsumoto T.K., Cotrim P.C., da Silveira J.F., et al. Trypanosoma cruzi: isolation of an immunodominant peptide of TESA (trypomastigote excreted-secreted antigens) by gene cloning. Diagn Microbiol Infect Dis 2002;42:187-92.
18. Silveira-Lacerda E.P., Silva A.G., Junior S.F., et al. Chagas' disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank. Vox Sang 2004;87:204-7.
19. Umezawa E.S., Silveira J.F. Serological diagnosis of Chagas disease with purified and defined Trypanosoma cruzi antigens. Mem Inst Oswaldo Cruz 1999;94:285-8.
20. Unti O., Silva T.L. da. Levantamento da moléstia de Chagas no estado de São Paulo pela reação sorológica. Arquivos de Higiene e Saúde Pública 1952:17:123-32.
21. Mello C da Silva A., Rocha e Silva E.O., et al. Estudo epidemiológico relativo à infecção chagásica no município de Taquarituba, SP, realizado no período de 1974 a 1976. In: Resumos do 19°. Congresso Brasileiro de Higiene. São Paulo, 1977.
22. Soares B.C., Proietti A.B., Proietti F.A. HTLV-I/II and blood donor: determinants associated with seropositivity in a low risk population. Rev Saúde Pública 2003;37:470-6.
23. Paltanin L.F., Reiche E.M.V. Seroprevalence of anti hepatitis C virus of antibodies among blood donors, Brazil. Revista de Saúde Pública. 2002;36:393-9.
24. Valente V.B., Covas D.T., Passos A.D.C. Hepatitis B and C serologic markers in blood donors of the Ribeirão Preto Blood Center. Rev Soc Bras Med Trop 2005;38;488-92.
25. Ishak R, Ishak MOG, Azevedo VN, et al. Detection of HTLV-IIa in blood donors in an urban area of the Amazon Region of Brazil (Belém, PA). Revista da Sociedade Brasileira de Medicina Tropical 1998; 31:139-97.
26. Prudêncio B.C.A.B., Covas D.T., Bonini-Domingos C.R. Comparação de metodologia utilizada para, a detecção de Hemoglobina S (Hb S) em doadores de sangue. Revista Brasileira de Hematologia e Hemoterapia 2000;22:99-109.
27. Borges VL, Martinez EZ, Bendini MH, Costa MAGF, Ferreira SCL. Reliability of a blood donor satisfaction questionnaire. Revista Brasileira de Epidemiologia 2005;8:177-86.
28. Lisot C.L.A., Silla L.M.R. Screening for hemoglobinopathies in blood donors from Caxias do Sul, Rio Grande do Sul, Brasil: prevalence in na Italian colony. Caderno de Saúde' Pública 2004; 20:1595-601.
29. Sobreira A.C.M., Gomes F.V.B.A.F., Silva M.A.M., Oliveira M.F. Chagasic infection prevalence in blood donors for the Hemocentro Regional de Iguatu. Revista da Sociedade Brasileira de Medicina Tropîcal 2001;34:193-6.
30. Kamiji M.M., Oliveira R.B. Features of Chagas' disease patients with emphasis on digestive form in a tertiary hospital of Ribeirão Preto. Rev Soc Bras Med/Trop 2005;38:305-9.
31. Oelemann W.M., Teixeira M.D., Verissimo da Costa G.C., et al. Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas'disease. J Clin Microbiol 1998;36:2423-7.
32. Ferreira A.W., Belem Z.R., Moura M.E.G., Camargo M.E. Aspectos da padronização de testes sorológicos para a doença de Chagas. Um teste imunoenzimático para a triagem de doadores de sangue. Revista do Instituto de Medicina Tropical de São Paulo 1991;33:123-8.
33. Hamerschlak N., Pasternak J., Amato Neto V., et al. Chagas' disease: an algorithm for donor screening and positive donor counseling. Rev Soc Bras Med Trop 1997;30:205-9.
34. Fuchs AP, Fioratti VL, de Mello VA, Boainain E. Serological diagnosis of Chagas' disease. Comparative study of various technics. Rev Inst Med Trop São Paulo 1980;22:242-5.
35. Camargo M.E., Hoshino-Shimizu S., Macedo V., et al. Serologic diagnosis of human Trypanosoma cruzi infection. Comparative study of complement fixation, immunofluorescence, hemagglutination and floculation tests in 3,624 serum samples. Rev Inst Med Trop São Paulo 1977; 19:254-60.
36. Gadelha AA, Vercosa AF, Lorena VM, et al. Chagas' diseade diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test. Vox Sang 2003;85:165-70.
37. Schmunis G.A. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991;31:547-57.
38. Saldana A., Souza O.E. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi. J Parasitol 1996;82:363-6.
39. Zambrano-Villa S., Rosales-Borjas D., Carrero J.C., et al. How protozoan parasites evade the immune response. Trends Parasitol 2002; 18:272-8.
40. Garcia I.E., Lima M.R., Marinho C.R., et al. Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance. J Parasitol 1997;83:230-3.
41. Machado C.R., Augusto-Pinto L., McCulloch R., Teixeira S.M. DNA metabolism and genetic diversity in Trypanosomes. Mutation Research 2006;612:40-57.
42. El-Sayed N.M., Myler P.J., Bartholomeu D.C., et al. The genome sequence of trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005;309:409-15.
43. Macedo A.M., Machado C.R., Oliveira R.P., Pena S.D. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. Mem Inst Oswaldo Cruz 2004;99:1-12.
44. Toledo M.J., Bahia M.T., Veloso V.M., et al. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. J Antimicrob Chemother 2004;53,1045-53.
45. Umezawa E.S., Nascimento M.S., Kesper Jr. N., et al. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas'disease. J Clin Microbiol 1996;34:2143-7.
46. Luz Z.M.P., Coutinho M.G., Cançado J.R., Krettli A.U. Hemoculture: sensitive technique in the detection of Trypanosoma cruzi in chagasic patients in the chronic phase of Chagas disease.Rev Soc Bras Med Trop 1994; 27:143-8.
47. Pinto PLS. Circulação e caracterização de Trypanosoma cruzi isolados de mamíferos silvestres capturados no Estado de São Paulo, Brasil. Revista do Instituto de Medicina Tropical São Paulo 2001;43:44.
48. Gomes M.L., Galvão L.M., Macedo A.M., et al. Chagas'disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. Am J Trop Med Hyg 1999;60(2):205-10.
49. Hernandez-Becerril N., Mejia A.M., Ballinas-Verdugo M.A., et al. Blood transfusion and iatrogenic risks in Mexico city. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. Mem Inst Oswaldo Cruz 2005;100(2):111-6.
50. Franco Y.B.A., Silva I.G., Rassi A., et al. Correlation among the positivity of the artificial xenodiagnosis and the amount of blood and triatomines used in the exam, in chronic chagasic patients. Revista da Sociedade Brasileira de Medicina Tropical. 2002;35:29-33.
51. Dias C., Nussenzweig V., Gonçales A. An improved polymerase chain reaction assay to detect Trypanosoma cruzi in blood. Am J Trop Med Hyg 1992;46:616-23.
52. Lucheis S. B., Da Silva A. V., Araújo Jr. J.P., et al. Trypanosomatids in dogs belonging to individuals with chronic Chagas' disease living in Botucatu town and surrounding region, São Paulo State, Brazil. Journal of Venomous Animals and Toxins including Tropical Diseases 2005;11:492-509.